✦ LIBER ✦

AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders

✍ Scribed by Mark A. Dawson; Jayne E. Curry; Kelly Barber; Philip A. Beer; Brent Graham; John F. Lyons; Caroline J. Richardson; Mike A. Scott; Tomoko Smyth; Matthew S. Squires; Neil T. Thompson; Anthony R. Green; Nicola G. Wallis

Book ID: 108676769
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 417 KB
Volume: 150
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08175.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The JAK2V617Ftyrosine kinase mutation in

The JAK2V617Ftyrosine kinase mutation in myeloproliferative disorders: Summary of published literature and a perspective

✍ Martha Wadleigh; D. Gary Gilliland 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 109 KB

Gö6976 is a potent inhibitor of the JAK

Gö6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells

✍ Victoria L. Grandage; Tamara Everington; David C. Linch; Asim Khwaja 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB